79 related articles for article (PubMed ID: 9119155)
1. Experimental experience with virus validation studies.
Willkommen H
Dev Biol Stand; 1996; 88():317-8. PubMed ID: 9119155
[No Abstract] [Full Text] [Related]
2. [Hepatitis C following administration of intravenous immunoglobulins].
Cabrera Chaves T; Simón Marco MA; Gomollón García F; Botella Esteban MT; Uribarrena Echebarría R
Gastroenterol Hepatol; 1996; 19(6):305-8. PubMed ID: 8754418
[TBL] [Abstract][Full Text] [Related]
3. Follow-up studies of hepatitis C association with an intravenous immunoglobulin.
Yu MW
Dev Biol Stand; 1996; 88():215-6. PubMed ID: 9119139
[No Abstract] [Full Text] [Related]
4. Hepatitis C and immune globulin.
López-Jiménez J; Odriozola J; Pérez-Oteyza J; García-Laraña J
N Engl J Med; 1995 May; 332(18):1235-6. PubMed ID: 7700324
[No Abstract] [Full Text] [Related]
5. 111 cases of hepatitis C linked to Gammagard. Patient screening recommended.
Am J Hosp Pharm; 1994 Oct; 51(19):2326. PubMed ID: 7847397
[No Abstract] [Full Text] [Related]
6. Hepatitis C and immune globulin.
Prince AM; Horowitz B
N Engl J Med; 1995 May; 332(18):1236; author reply 1236-7. PubMed ID: 7700325
[No Abstract] [Full Text] [Related]
7. Hepatitis C and immune globulin.
Douglas SD; Slade HB
N Engl J Med; 1995 May; 332(18):1235; author reply 1236-7. PubMed ID: 7700323
[No Abstract] [Full Text] [Related]
8. Transmission of viral infections through intravenous immune globulin.
Schiff RI
N Engl J Med; 1994 Dec; 331(24):1649-50. PubMed ID: 7969346
[No Abstract] [Full Text] [Related]
9. Transmission of hepatitis after the administration of intravenous immunoglobulins.
Rousell RH; Dobkin MB; Budinger MD; Louie RE
Am J Clin Pathol; 1993 May; 99(5):649. PubMed ID: 8493958
[No Abstract] [Full Text] [Related]
10. Follow-up of four HIV-infected individuals after administration of hepatitis C virus and GBV-C/hepatitis G virus contaminated intravenous immunoglobulin: evidence for HCV but not for GBV-C/HGV transmission.
Berger A; Doerr HW; Scharrer I; Weber B
J Med Virol; 1997 Sep; 53(1):25-30. PubMed ID: 9298728
[TBL] [Abstract][Full Text] [Related]
11. Viral transmission by blood products: a perspective of events covered by the recent tribunal of enquiry into the Irish Blood Transfusion Board.
Yap PL
Ir Med J; 1997; 90(3):84, 86, 88. PubMed ID: 9183082
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C from immunoglobin infusions.
Lehner PS; Webster AD
BMJ; 1993 Jun; 306(6891):1541-2. PubMed ID: 8518699
[No Abstract] [Full Text] [Related]
13. HCV and Gammagard in France.
Gomperts ED
Lancet; 1994 Jul; 344(8916):201. PubMed ID: 7912801
[No Abstract] [Full Text] [Related]
14. Outcome of intravenous immunoglobulin-transmitted hepatitis C virus infection in primary immunodeficiency.
Razvi S; Schneider L; Jonas MM; Cunningham-Rundles C
Clin Immunol; 2001 Dec; 101(3):284-8. PubMed ID: 11726220
[TBL] [Abstract][Full Text] [Related]
15. Infectious hazards of immune globulin.
Barton LL
J Pediatr; 1995 Feb; 126(2):321-2. PubMed ID: 7844688
[No Abstract] [Full Text] [Related]
16. Development of working reagents and international standards.
Saldanha J
Biologicals; 1998 Jun; 26(2):115-7. PubMed ID: 9811516
[No Abstract] [Full Text] [Related]
17. Intravenous immunoglobulins.
Webster AD
BMJ; 1991 Aug; 303(6799):375-6. PubMed ID: 1912799
[No Abstract] [Full Text] [Related]
18. Safety of intravenous immunoglobulin with regard to hepatitis C virus.
Yu MW; Mason BL; Guo ZP; Tankersley DL
Clin Ther; 1996; 18 Suppl B():71-2. PubMed ID: 8930443
[No Abstract] [Full Text] [Related]
19. Intravenous immunoglobulin and hepatitis C virus: the British episode.
Healey C; Chapel H
Clin Ther; 1996; 18 Suppl B():93-5. PubMed ID: 8930446
[No Abstract] [Full Text] [Related]
20. Use and interpretation of virological tests for hepatitis C.
Pawlotsky JM
Hepatology; 2002 Nov; 36(5 Suppl 1):S65-73. PubMed ID: 12407578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
